Penserra Capital Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-8,052	Closed	-$921K	–	1158
2020 Q3	$921K	Sell	8,052 -1,087	-12%	-$117K	0.04%	278
2020 Q2	$1.02M	Sell	9,139 -3,084	-25%	-$327K	0.05%	265
2020 Q1	$1.19M	Buy	12,223 +246	+2%	+$24.1K	0.08%	230
2019 Q4	$1.29M	Buy	11,977 +11,791	+6,339%	+$1.26M	0.08%	262
2019 Q3	$18K	Sell	186 -969	-84%	-$109K	﹤0.01%	752
2019 Q2	$151K	Sell	1,155 -17,820	-94%	-$2.3M	0.01%	431
2019 Q1	$2.58M	Buy	+18,975	New	+$2.36M	0.21%	88
2018 Q4	–	Sell	-2,300	Closed	-$319K	–	817
2018 Q3	$319K	Sell	2,300 -16,270	-88%	-$2.04M	0.02%	362
2018 Q2	$2.31M	Buy	18,570 +16,746	+918%	+$1.96M	0.15%	108
2018 Q1	$203K	Buy	1,824 +144	+9%	+$17.2K	0.02%	253
2017 Q4	$200K	Buy	1,680 +264	+19%	+$32.2K	0.03%	220
2017 Q3	$199K	Buy	1,416 +168	+13%	+$22.8K	0.05%	203
2017 Q2	$151K	Buy	1,248 +144	+13%	+$16.8K	0.05%	251
2017 Q1	$133K	Sell	1,104 -37	-3%	-$4.77K	0.01%	273
2016 Q4	$139K	Buy	1,141 +347	+44%	+$42.5K	0.02%	286
2016 Q3	$96K	Buy	794 +386	+95%	+$49.7K	0.01%	281
2016 Q2	$48K	Buy	408 +139	+52%	+$19.7K	0.01%	355
2016 Q1	$36	Buy	269 +85	+46%	+$12.5K	﹤0.01%	348
2015 Q4	$35K	Buy	+184	New	+$32.1K	﹤0.01%	293